Breaking News from CBS on EpiPen revenue

Debra Reynolds

Mylan CEO faces backlash over skyrocketing pricing for the EpiPen.  Estimated to bring in over $1.1 billion in revenue, marketing costs are only estimated at $85 million.

Read the full story at : http://www.cbsnews.com/news/epipen-price-hike-mylan-ceo-heather-bresch-testifies-congress-documents-profit/

skyrocketing-epipen-prices